Firm News

Netlist Secures Nearly
$1.5 Billion in Patent Licensing Agreements

Sterne Kessler represented Netlist in disputes leading to five-year agreements with Samsung and Micron.

Firm News

Sterne Kessler Advises IntraBio in $2 Billion Sale to Shionogi

Firm News

Sterne Kessler and Thomson Reuters Partner to Create New AI Tool for Patent Litigation

Award

Sterne Kessler and Director Eldora Ellison Win Top Awards

2026 Life Sciences Americas Awards

A Powerhouse Firm When You Want a Deep Understanding of IP Law.

Chambers & Partners

Award

Sterne Kessler Named “Distinguished” Firm for IP Litigation and “Leader” in Generative AI Litigation

BTI Litigation Outlook 2027

Firm News October 15, 2026
Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions

Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions

Washington, D.C. (October 15, 2026) – Sterne, Kessler, Goldstein & Fox (Sterne Kessler), a market leading intellectual property (IP) law firm, today announced a co-development partnership with Clarivate…

Learn more about Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions
Articles October 13, 2026
Patent Claim Quality and Scope: Why What a Patent Claims Matters More Than Whether It Exists

Patent Claim Quality and Scope: Why What a Patent Claims Matters More Than Whether It Exists

Part 2 of a Ten-part series: Intellectual Property as a Value Driver and Risk Factor in Life Sciences Venture Investment Introduction For venture capital investors in the life…

Learn more about Patent Claim Quality and Scope: Why What a Patent Claims Matters More Than Whether It Exists
Articles October 7, 2026
Key Takeaways: Navigating Follow-On Patents in Bio-Pharma

Key Takeaways: Navigating Follow-On Patents in Bio-Pharma

Recent case law and evolving U.S. Patent and Trademark Office (USPTO) practices are raising the stakes for how follow-on patent portfolios are drafted, prosecuted, defended, and challenged. In…

Learn more about Key Takeaways: Navigating Follow-On Patents in Bio-Pharma
Client Alert October 6, 2026
Transformative Means More Than “Powered by AI”

Transformative Means More Than “Powered by AI”

Last week, the Third Circuit issued one of the first appellate rulings on copyright and AI training in Thomson Reuters v. ROSS Intelligence. The court held Westlaw’s headnotes…

Learn more about Transformative Means More Than “Powered by AI”
Firm News October 1, 2026
Sterne Kessler and Directors Recognized in IAM and WTR’s Inaugural Copyright 1000

Sterne Kessler and Directors Recognized in IAM and WTR’s Inaugural Copyright 1000

Washington, D.C. (October 1, 2026) – Sterne, Kessler, Goldstein & Fox and two directors were ranked in the inaugural edition of Intellectual Asset Management (IAM) and World Trademark…

Learn more about Sterne Kessler and Directors Recognized in IAM and WTR’s Inaugural Copyright 1000
Articles September 30, 2026
How “Material Error” Has Become Key To Avoiding Discretionary Denial at the PTAB

How “Material Error” Has Become Key To Avoiding Discretionary Denial at the PTAB

Former associate, Tyler Drye, contributed to this article. Introduction Discretionary denial has long been one of the most important—and sometimes unpredictable—features of PTAB practice. Although the statutory bases…

Learn more about How “Material Error” Has Become Key To Avoiding Discretionary Denial at the PTAB

Your innovations are worth the best protection

As one of the largest and most diverse intellectual property firms in the United States, Sterne Kessler has the experience to handle your most complex IP challenges. From litigation to patent and trademark prosecution, practicing at the Patent Trial and Appeal Board, and general IP strategy, we have the right team for your needs.
Find a Professional
View All Professionals

Find by Last Name

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Expertise

Sterne Kessler is a full-service IP firm that delivers innovative solutions tailored to your business and industry.